# Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI

> **NCT04555642** · — · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 120 (estimated)

## Conditions studied

- Positron-Emission Tomography
- Magnetic Resonance Imaging

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04555642
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-15
- **Primary completion:** 2021-12-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04555642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04555642, "Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04555642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*